Reply to ‘Interpreting day‐7 CAR ‐T expansion in large B‐cell lymphoma: Timing and baseline risk adjustment’
British Journal of Haematology · 29.10.2026
DOI: 10.1111/bjh.70919 ↗Kurz gefasst
Leserbrief in der Zeitschrift British Journal of Haematology, online erschienen am 29.10.2026. Verfasst von Brydon Panozzo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia.
- Malignant Haematology, Transplantation and Cellular Therapy Service, Alfred Hospital, Melbourne, Victoria, Australia.
- Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
- Centre of Excellence in Cellular Immunotherapy, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
ORCID-Profile: Brydon Panozzo, Mark R Dowling
Zitieren
APA
Panozzo, B., Robinson, S., Westerman, D. A., & Dowling, M. R. (2026). Reply to ‘Interpreting day‐7 CAR ‐T expansion in large B‐cell lymphoma: Timing and baseline risk adjustment’. British Journal of Haematology. https://doi.org/10.1111/bjh.70919
Vancouver
Panozzo B, Robinson S, Westerman DA, Dowling MR. Reply to ‘Interpreting day‐7 CAR ‐T expansion in large B‐cell lymphoma: Timing and baseline risk adjustment’. British Journal of Haematology. 2026. doi:10.1111/bjh.70919
BibTeX
@article{Panozzo2026,
author = {Panozzo, Brydon and Robinson, Samuel and Westerman, David A and Dowling, Mark R},
title = {Reply to ‘Interpreting day‐7 CAR ‐T expansion in large B‐cell lymphoma: Timing and baseline risk adjustment’},
journal = {British Journal of Haematology},
year = {2026},
doi = {10.1111/bjh.70919}
}
EUVIMED